
Inogen, Inc. – NASDAQ:INGN
Inogen stock price today
Inogen stock price monthly change
Inogen stock price quarterly change
Inogen stock price yearly change
Inogen key metrics
Market Cap | 198.40M |
Enterprise value | 141.18M |
P/E | -3.52 |
EV/Sales | 0.39 |
EV/EBITDA | -1.30 |
Price/Sales | 0.84 |
Price/Book | 1.02 |
PEG ratio | N/A |
EPS | -4.14 |
Revenue | 321.52M |
EBITDA | -11.11M |
Income | -96.67M |
Revenue Q/Q | 8.12% |
Revenue Y/Y | -12.87% |
Profit margin | -37.83% |
Oper. margin | -10.09% |
Gross margin | 37.78% |
EBIT margin | -10.09% |
EBITDA margin | -3.46% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeInogen stock price history
Inogen stock forecast
Inogen financial statements
Jun 2023 | 83.63M | -9.82M | -11.75% |
---|---|---|---|
Sep 2023 | 83.96M | -45.71M | -54.45% |
Dec 2023 | 75.89M | -26.55M | -34.99% |
Mar 2024 | 78.02M | -14.57M | -18.68% |
Sep 2025 | 90.66M | -7.41M | -8.18% |
---|---|---|---|
Oct 2025 | 88.50M | -9.24M | -10.44% |
Dec 2025 | 82.55M | -9.82M | -11.91% |
Mar 2026 | 82.29M | -12.94M | -15.73% |
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 374351000 | 99.57M | 26.6% |
---|---|---|---|
Sep 2023 | 343696000 | 113.06M | 32.9% |
Dec 2023 | 326194000 | 121.38M | 37.21% |
Mar 2024 | 315599000 | 123.70M | 39.2% |
Jun 2023 | 4.03M | -540K | -33K |
---|---|---|---|
Sep 2023 | 2.18M | -45.79M | 448K |
Dec 2023 | -3.14M | 4.12M | -14K |
Mar 2024 | -4.74M | -13.44M | 285K |
Inogen alternative data
Aug 2023 | 1,026 |
---|---|
Sep 2023 | 1,026 |
Oct 2023 | 1,026 |
Nov 2023 | 1,026 |
Dec 2023 | 1,026 |
Jan 2024 | 1,026 |
Feb 2024 | 1,026 |
Mar 2024 | 834 |
Apr 2024 | 834 |
May 2024 | 834 |
Jun 2024 | 834 |
Jul 2024 | 834 |
Inogen other data
Period | Buy | Sel |
---|---|---|
May 2024 | 0 | 10000 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Option | SMITH KEVIN RAYMOND MERRILL director, officer: CEO and Pres.. | Restricted Stock Unit | 28,333 | N/A | N/A | ||
Option | SMITH KEVIN RAYMOND MERRILL director, officer: CEO and Pres.. | Common Stock | 28,333 | N/A | N/A | ||
Option | RAMADE GREGOIRE officer: Chief Co.. | Restricted Stock Unit | 31,565 | N/A | N/A | ||
Option | RAMADE GREGOIRE officer: Chief Co.. | Common Stock | 31,565 | N/A | N/A | ||
Option | SOMER JASON officer: EVP, Gen. Counsel & Se.. | Common Stock | 577 | N/A | N/A | ||
Option | SOMER JASON officer: EVP, Gen. Counsel & Se.. | Restricted Stock Unit | 577 | N/A | N/A | ||
Sale | SOMER JASON officer: EVP, Gen. Counsel & Se.. | Common Stock | 10,000 | $8.56 | $85,600 | ||
Option | GLEZER STANISLAV officer: EVP, R&D & Chief Med. .. | Restricted Stock Unit | 32,638 | N/A | N/A | ||
Option | SOMER JASON officer: EVP, Gen. Counsel & Se.. | Common Stock | 19,276 | N/A | N/A | ||
Option | SOMER JASON officer: EVP, Gen. Counsel & Se.. | Restricted Stock Unit | 19,276 | N/A | N/A |
Patent |
---|
Grant Utility: Compact portable oxygen concentrator Filling date: 1 Apr 2020 Issue date: 5 Apr 2022 |
Grant Design: Hand-held ventilator Filling date: 17 Jun 2019 Issue date: 5 Apr 2022 |
Grant Design: Oxygen concentrator battery Filling date: 1 Apr 2019 Issue date: 11 Jan 2022 |
Application Filling date: 6 Aug 2021 Issue date: 25 Nov 2021 |
Grant Design: Oxygen concentrator Filling date: 1 Apr 2019 Issue date: 14 Sep 2021 |
Grant Design: Nasal interface for ventilation Filling date: 24 Feb 2020 Issue date: 7 Sep 2021 |
Application Filling date: 18 Dec 2020 Issue date: 12 Aug 2021 |
Grant Utility: Compact portable oxygen concentrator Filling date: 30 May 2017 Issue date: 10 Aug 2021 |
Application Filling date: 25 Sep 2020 Issue date: 18 Mar 2021 |
Application Filling date: 5 Oct 2020 Issue date: 21 Jan 2021 |
Quarter | Transcript |
---|---|
Q1 2024 7 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 27 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 7 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 7 Aug 2023 | Q2 2023 Earnings Call Transcript |
Insider | Compensation |
---|---|
Ms. Alison Perry Bauerlein (1981) Co-Founder | $373,490 |
Mr. Bart Sanford (1966) Executive Vice President of Operations | $330,750 |
-
What's the price of Inogen stock today?
One share of Inogen stock can currently be purchased for approximately $7.49.
-
When is Inogen's next earnings date?
Unfortunately, Inogen's (INGN) next earnings date is currently unknown.
-
Does Inogen pay dividends?
No, Inogen does not pay dividends.
-
How much money does Inogen make?
Inogen has a market capitalization of 198.40M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 16.32% to 315.66M US dollars.
-
What is Inogen's stock symbol?
Inogen, Inc. is traded on the NASDAQ under the ticker symbol "INGN".
-
What is Inogen's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Inogen?
Shares of Inogen can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Inogen's key executives?
Inogen's management team includes the following people:
- Ms. Alison Perry Bauerlein Co-Founder(age: 44, pay: $373,490)
- Mr. Bart Sanford Executive Vice President of Operations(age: 59, pay: $330,750)
-
Is Inogen founder-led company?
Yes, Inogen is a company led by its founder Ms. Alison Perry Bauerlein.
-
How many employees does Inogen have?
As Jul 2024, Inogen employs 834 workers.
-
When Inogen went public?
Inogen, Inc. is publicly traded company for more then 11 years since IPO on 14 Feb 2014.
-
What is Inogen's official website?
The official website for Inogen is inogen.com.
-
Where are Inogen's headquarters?
Inogen is headquartered at 301 Coromar Drive, Goleta, CA.
-
How can i contact Inogen?
Inogen's mailing address is 301 Coromar Drive, Goleta, CA and company can be reached via phone at 805 562 0500.
Inogen company profile:

Inogen, Inc.
inogen.comNASDAQ
834
Medical - Devices
Healthcare
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Goleta, CA 93117
CIK: 0001294133
ISIN: US45780L1044
CUSIP: 45780L104